Literature DB >> 7787000

Heterogeneity models of disease susceptibility, with application to diabetic nephropathy.

P Hougaard1, P Myglegaard, K Borch-Johnsen.   

Abstract

It is not, in general, possible to include all relevant risk factors in a model of survival or disease incidence. This heterogeneity must be accounted for in the interpretation, as it can imply otherwise unexpected results. This is illustrated by diabetic nephropathy, a serious complication experienced by some diabetic patients. A mathematical model with varying susceptibility can explain that the incidence increases until 20 years duration of diabetes and later decreases. The hospital-based data cover patients diagnosed during 1933-1972. They are interval censored, because early detection of nephropathy requires chemical analysis of urine samples. The data are consistent with a model where less than half of the patients are susceptible, and for each of these the hazard is increasing. The estimated degree of heterogeneity markedly depends on the assumed model. The dependence on age at onset and calendar time of onset is examined. The highest risk is seen at onset age 13-17 years, and the risk decreases with calendar time. The effect of covariates on the hazard is markedly different for the various models, but this is partly a matter of parametrization, as the disagreement is reduced by a reparametrization inspired by accelerated failure time models.

Entities:  

Mesh:

Year:  1994        PMID: 7787000

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  11 in total

1.  How to survive diabetes.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2009-04       Impact factor: 10.122

Review 2.  Frailty models for survival data.

Authors:  P Hougaard
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

3.  Modelling conditional distributions in bivariate survival.

Authors:  R Henderson
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

4.  Prevalent cohort studies and unobserved heterogeneity.

Authors:  Niels Keiding; Katrine Lykke Albertsen; Helene Charlotte Rytgaard; Anne Lyngholm Sørensen
Journal:  Lifetime Data Anal       Date:  2019-07-03       Impact factor: 1.588

5.  Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients.

Authors:  Hyeong-Seok Lim; Wan Sun; Kourosh Parivar; Diane Wang
Journal:  AAPS J       Date:  2019-01-30       Impact factor: 4.009

Review 6.  How the effects of aging and stresses of life are integrated in mortality rates: insights for genetic studies of human health and longevity.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Liubov S Arbeeva; Deqing Wu; Igor Akushevich; Mikhail Kovtun; Arseniy Yashkin; Alexander Kulminski; Irina Culminskaya; Eric Stallard; Miaozhu Li; Svetlana V Ukraintseva
Journal:  Biogerontology       Date:  2015-08-18       Impact factor: 4.277

7.  Improving Our Ability to Evaluate Underlying Mechanisms of Behavioral Onset and Other Event Occurrence Outcomes: A Discrete-Time Survival Mediation Model.

Authors:  Amanda J Fairchild; Winston E Abara; Amanda C Gottschall; Jenn-Yun Tein; Ronald J Prinz
Journal:  Eval Health Prof       Date:  2013-12-02       Impact factor: 2.651

8.  Modeling smoking cessation data with alternating states and a cure fraction using frailty models.

Authors:  Yimei Li; E Paul Wileyto; Daniel F Heitjan
Journal:  Stat Med       Date:  2010-03-15       Impact factor: 2.373

9.  Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX.

Authors:  Eric J Oh; Bryan E Shepherd; Thomas Lumley; Pamela A Shaw
Journal:  Stat Med       Date:  2017-11-29       Impact factor: 2.373

10.  Multidimensional Mortality Selection: Why Individual Dimensions of Frailty Don't Act Like Frailty.

Authors:  Elizabeth Wrigley-Field
Journal:  Demography       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.